130 Publications (Page 5 of 6)
2010
Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer.
Blackwell, Kimberly LBurstein, Harold JStorniolo, Anna MRugo, Hope SSledge, GeorgeKoehler, MariaEllis, CatherineCasey, MichelleVukelja, SvetislavaBischoff, JoachimBaselga, Jose and O'Shaughnessy, Joyce
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 28, (no. 7), pp. 1124-30, 2010/Mar/1. | Journal Article
2009
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort.
Henry, Norah LHenry, N LynnRae, JamesRae, James MLi, LangLi, LangAzzouz, FaouziAzzouz, FaouziSkaar, Todd CSkaar, Todd CDesta, ZereunesayDesta, ZereunesaySikora, Matthew JSikora, Matthew JPhilips, SantoshPhilips, SantoshNguyen, Anne TNguyen, Anne TStorniolo, Anna MariaStorniolo, Anna MHayes, Daniel FHayes, Daniel FFlockhart, David AFlockhart, David AStearns, Vered and Stearns, Vered
Breast cancer research and treatment, vol. 117, (no. 3), pp. 571-5, 2009/Oct. | Journal Article
 
Cognitive Dysfunction and Its Relationship to Quality of Life in Breast Cancer Survivors.
Von Ah, DianeVon Ah, DianeVon Ah, DianeRussell, Kathleen MRussell, Kathleen MRussell, Kathleen MStorniolo, Anna MariaStorniolo, Anna MariaStorniolo, Anna MariaCarpenter, Janet SCarpenter, Janet S and Carpenter, Janet S
Oncology nursing forum, vol. 36, (no. 3), pp. 326-336, May 1, 2009. | Journal Article
 
Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy.
Otte, Julie LFlockhart, David AHayes, Daniel FStorniolo, Anna MStearns, VeredSchneider, Bryan PHenry, Norah LAzzouz, FaouziNguyen, AnneLemler, SuzanneHayden, JillJeter, StacieWright, Laurie and Carpenter, Janet S
Menopause (New York, N.Y.), vol. 16, (no. 4), pp. 653-9, 2009 Jul-Aug. | Journal Article
 
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.
Rae, JamesSikora, M JHenry, Norah LLi, LKim, SOesterreich, SteffiSkaar, Todd CNguyen, A TDesta, ZeruesenayStorniolo, Anna MFlockhart, David AHayes, Daniel F and Stearns, Vered
The pharmacogenomics journal, vol. 9, (no. 4), pp. 258-64, 2009/Aug. | Journal Article
 
Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion.
Carpenter, JanetCarpenter, JanetCarpenter, Janet SYu, MenggangYu, MenggangYu, MenggangWu, JingweiWu, JingweiWu, JingweiVon Ah, DianeVon Ah, DianeVon Ah, DianeMilata, JenniferMilata, JenniferMilata, JenniferOtte, JulieOtte, JulieOtte, Julie LJohns, ShelleyJohns, ShelleyJohns, ShelleySchneider, BryanSchneider, BryanSchneider, Bryan PStorniolo, Anna MStorniolo, AnnaStorniolo, AnnaSalomon, RonaldSalomon, RonaldSalomon, RonaldDesta, ZeuresenayDesta, ZeuresenayDesta, ZeuresenayCao, DonghuaCao, DonghuaCao, DonghuaJin, YanJin, YanJin, YanPhilips, SantoshPhilips, SantoshPhilips, SantoshSkaar, ToddSkaar, Todd C and Skaar, Todd
Menopause (New York, N.Y.), vol. 16, (no. 4), pp. 644-52, 2009 Jul-Aug. | Journal Article
 
Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes
Schneider, Bryan PRadovich, MilanFlockhart, David ACarpenter, Janet SLi, LangRobarge, Jason DStorniolo, Anna MHancock, Bradley ASkaar, Todd and Sledge, George W
Breast Cancer Research and Treatment, vol. 116, (no. 3), pp. 543-9, Aug 2009. | Journal Article
2008
A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer
Burstein, Harold JStorniolo, Anna MFranco, S.Forster, J.Stein, S.Rubin, S.Salazar, V. M and Blackwell, Kimberly L
Annals of Oncology, vol. 19, (no. 6), pp. 1068-74, Jun 2008. | Journal Article
 
Association of polymorphisms of angiogenesis genes with breast cancer
Schneider, Bryan PRadovich, MilanSledge, George WRobarge, Jason DLi, LangStorniolo, Anna MLemler, SuzanneNguyen, Anne THancock, Bradley AStout, MichaelSkaar, Todd and Flockhart, David A
Breast Cancer Research and Treatment, vol. 111, (no. 1), pp. 157-63, Sep 2008. | Journal Article
 
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.
Jin, YanJin, YanJin, YanHayes, DanielHayes, DanielHayes, Daniel FLi, LangLi, LangLi, LangRobarge, Jason DRobarge, JasonRobarge, JasonSkaar, ToddSkaar, Todd CSkaar, ToddPhilips, SantoshPhilips, SantoshPhilips, SantoshNguyen, AnneNguyen, AnneNguyen, AnneSchott, AnneSchott, AnneSchott, AnneHayden, JillHayden, JillHayden, JillLemler, SuzanneLemler, SuzanneLemler, SuzanneStorniolo, AnnaStorniolo, Anna MStorniolo, AnnaFlockhart, DavidFlockhart, David AFlockhart, DavidStearns, VeredStearns, Vered and Stearns, Vered
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 26, (no. 36), pp. 5849-54, 2008/Dec/20. | Journal Article
 
Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancer.
Storniolo, Anna MPegram, Mark DOvermoyer, BethSilverman, PaulaPeacock, Nancy WJones, Suzanne FLoftiss, JillArya, NikitaKoch, Kevin MPaul, ElainePandite, LiniFleming, Ronald ALebowitz, Peter FHo, Peter T and Burris, Howard A
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 26, (no. 20), pp. 3317-23, 2008/Jul/10. | Journal Article
 
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.
Henry, Norah LGiles, Jon TAng, DennisMohan, MonikaDadabhoy, DinaRobarge, JasonHayden, JillLemler, SuzanneShahverdi, KarinehPowers, PennyLi, LangFlockhart, David AStearns, VeredHayes, Daniel FStorniolo, Anna M and Clauw, Daniel J
Breast cancer research and treatment, vol. 111, (no. 2), pp. 365-72, 2008/Sep. | Journal Article
 
Quality of Life of African American Breast Cancer Survivors: How Much Do We Know?
Russell, Kathleen MVon Ah, DianeGiesler, Raymond BStorniolo, Anna M and Haase, Joan E
Cancer Nursing, vol. 31, (no. 6), Nov/Dec 2008. | Journal Article
2007
Cognitive-behavioral intervention for hot flashes.
Carpenter, Janet SNeal, Jennifer GPayne, Judith KKimmick, Gretchen and Storniolo, Anna M
Oncology nursing forum, vol. 34, (no. 1), pp. 37, 2007/Jan. | Journal Article
 
Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer
James, JehanaMurry, Daryl JTreston, Anthony MStorniolo, Anna MSledge, George WSidor, Carolyn and Miller, Kathy D
Investigational New Drugs, vol. 25, (no. 1), pp. 41-8, Feb 2007. | Journal Article
 
Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Carpenter, Janet SCarpenter, JanetStorniolo, Anna MStorniolo, AnnaJohns, ShelleyJohns, ShelleyMonahan, Patrick OMonahan, PatrickAzzouz, FaouziAzzouz, FaouziElam, Julie LElam, JulieJohnson, CynthiaJohnson, Cynthia SShelton, Richard C and Shelton, Richard
The oncologist, vol. 12, (no. 1), pp. 124-35, 2007/Jan. | Journal Article
2006
Quality of life of husbands of women with breast cancer
Wagner, ChristinaBigatti, Silvia M and Storniolo, Anna M
Psycho - Oncology, vol. 15, (no. 2), pp. 109-120, Feb 2006. | Journal Article
 
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment.
Borges, SilvanaDesta, ZeruesenayLi, LangSkaar, Todd CWard, Bryan ANguyen, AnneJin, YanStorniolo, Anna MNikoloff, D MWu, LinHillman, GrantHayes, Daniel FStearns, Vered and Flockhart, David A
Clinical pharmacology and therapeutics, vol. 80, (no. 1), pp. 61-74, 2006/Jul. | Journal Article
2005
CYP2D6 genotype and tamoxifen response.
Rae, JamesGoetz, Matthew PHayes, Daniel FIngle, James NLi, LangStorniolo, Anna MStearns, Vered and Flockhart, David A
Breast cancer research : BCR, vol. 7, (no. 5), pp. E6, 2005. | Journal Article
 
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
Jin, YanDesta, ZeruesenayStearns, VeredWard, BryanHo, HerbertLee, Kyung-HoonSkaar, Todd CStorniolo, Anna MLi, LangAraba, AdjeiBlanchard, RebeccaNguyen, AnneUllmer, LyndaHayden, JillLemler, SuzanneWeinshilboum, Richard MRae, JamesHayes, Daniel F and Flockhart, David A
Journal of the National Cancer Institute, vol. 97, (no. 1), pp. 30-9, 2005/Jan/5. | Journal Article
 
Is sternal skin conductance monitoring a valid measure of hot flash intensity or distress?
Carpenter, Janet SAzzouz, FaouziMonahan, Patrick OStorniolo, Anna M and Ridner, Sheila H
Menopause (New York, N.Y.) , vol. 12, (no. 5), pp. 512-9, 2005 Sep-Oct. | Journal Article
1999
An investigational new drug treatment program for patients with gemcitabine
Storniolo, Anna MariaEnas, Nathan HBrown, Cheryl AVoi, MaurizioRothenberg, Mace L and Schilsky, Richard
Cancer, vol. 85, (no. 6), pp. 1268, 1999-03-15. | Journal Article
 
An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinoma.
Storniolo, Anna MEnas, N HBrown, C AVoi, MRothenberg, M L and Schilsky, R
Cancer, vol. 85, (no. 6), pp. 1261-8, 1999/Mar/15. | Journal Article
 
A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy.
Fung, M CStorniolo, Anna MNguyen, BArning, MBrookfield, W and Vigil, J
Cancer, vol. 85, (no. 9), pp. 2023-32, 1999/May/1. | Journal Article
1997
Preclinical, pharmacologic, and phase I studies of gemcitabine.
Storniolo, Anna MAllerheiligen, S R and Pearce, H L
Seminars in Oncology, vol. 24, (no. 2 Suppl 7), pp. S7-2-S7-7, 1997/Apr. | Journal Article